These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20827122)

  • 21. Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR.
    Resmini E; Murialdo G; Giusti M; Boschetti M; Minuto F; Ferone D
    J Endocrinol Invest; 2005 Feb; 28(2):166-9. PubMed ID: 15887864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of acromegaly in Aarhus University Hospital. A retrospective investigation of the period from 1994 to 2004].
    Madsen M; Matthiesen EB; Poulsen PL; Weeke J; Astrup J; Jørgensen JO
    Ugeskr Laeger; 2007 Mar; 169(10):907-10. PubMed ID: 17359734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary octreotide LAR therapy in GH-secreting pituitary adenoma.
    Harinarayan CV
    J Indian Med Assoc; 2004 May; 102(5):258, 260-1. PubMed ID: 15636029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term changes in serum IGF-1 levels after successful surgical treatment of growth hormone-secreting pituitary adenoma.
    Shin MS; Yu JH; Choi JH; Jung CH; Hwang JY; Cho YH; Kim CJ; Kim MS
    Neurosurgery; 2013 Sep; 73(3):473-9; quiz 479. PubMed ID: 23728452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acromegaly presenting with diabetic ketoacidosis, associated with retinitis pigmentosa and octreotide-induced bradycardia: a case report and a review of the literature.
    Erem C; Ersöz HO; Ukinç K; Avunduk AM; Hacihasanoglu A; Koçak M
    Endocrine; 2006 Aug; 30(1):145-9. PubMed ID: 17185803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent remission of acromegaly in a patient with GH-secreting pituitary adenoma: Effect of treatment with pasireotide long-acting release and consequence of treatment withdrawal.
    Yu N; Wang L; Yang H; Pan H; Duan L; Zhu H
    J Clin Pharm Ther; 2022 Jun; 47(6):835-840. PubMed ID: 35167717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Severe cardiovascular complications due to the pituitary adenoma with acromegaly. An interdisciplinary approach to the treatment. A case report].
    Zieliński G; Hendzel P; Szałański P; Gołowicz J; Gryszko L; Podgórski JK
    Neurol Neurochir Pol; 2006; 40(4):354-60. PubMed ID: 16967359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inoperable Giant Growth Hormone-secreting Pituitary Adenoma: Radiological Aspects, Clinical Management and Pregnancy Outcome.
    Dicuonzo F; Purciariello S; De Marco A; Guastamacchia E; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):214-220. PubMed ID: 30088454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression.
    Leporati P; Fonte R; de Martinis L; Zambelli A; Magri F; Pavesi L; Rotondi M; Chiovato L
    BMC Cancer; 2015 May; 15():397. PubMed ID: 25962899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegvisomant: Balance after 10 years.
    Bernabeu I; Marazuela M
    Endocrinol Nutr; 2015 Oct; 62(8):363-5. PubMed ID: 26242927
    [No Abstract]   [Full Text] [Related]  

  • 31. A case of juvenile acromegaly that was initially diagnosed as severe congestive heart failure from acromegaly-induced dilated cardiomyopathy.
    Sue M; Yoshihara A; Okubo Y; Ishikawa M; Ando Y; Hiroi N; Shibuya K; Yoshino G
    Intern Med; 2010; 49(19):2117-21. PubMed ID: 20930439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy associated with recurrent acromegaly: a case report.
    Edo AE; Eregie A
    West Afr J Med; 2010; 29(2):120-2. PubMed ID: 20544639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical progress: Acromegaly.
    Melmed S
    N Engl J Med; 2006 Dec; 355(24):2558-73. PubMed ID: 17167139
    [No Abstract]   [Full Text] [Related]  

  • 34. [Akromegaly and pharmacotherapy].
    Šiprová H; Souček M
    Vnitr Lek; 2015 Feb; 61(2):157-60. PubMed ID: 25813261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoma size and postoperative IGF-1 levels predict surgical outcomes in acromegaly patients: results of the Swiss Pituitary Registry (SwissPit).
    Kempf J; Schmitz A; Meier A; Delfs N; Mueller B; Fandino J; Schuetz P; Berkmann S
    Swiss Med Wkly; 2018 Aug; 148():w14653. PubMed ID: 30141524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early surgical intervention for patients with possible clinically silent somatotroph adenoma: a case series.
    Kawaguchi T; Ogawa Y; Tominaga T
    J Med Case Rep; 2019 Mar; 13(1):85. PubMed ID: 30862315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery for acromegaly: Indications and goals.
    Bray DP; Mannam S; Rindler RS; Quillin JW; Oyesiku NM
    Front Endocrinol (Lausanne); 2022; 13():924589. PubMed ID: 35992136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poorly-controlled acromegaly accompanied by subclinical adrenal Cushing's syndrome after surgery for multiple endocrine tumors.
    Ishikawa M; Kato M; Sasaki H; Morii T; Fujita H; Kakei M; Narita T; Yamada Y
    Intern Med; 2015; 54(6):617-20. PubMed ID: 25786452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly.
    Losa M; Bollerslev J
    Endocrine; 2016 Jun; 52(3):451-7. PubMed ID: 26785848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of temozolomide in the treatment of a patient with a pure silent pituitary somatotroph carcinoma.
    Vieira Neto L; Chimelli L; Pereira PJ; Gasparetto EL; Bines J; Wildemberg LE; Gadelha MR
    Endocr Pract; 2013; 19(6):e145-9. PubMed ID: 23807517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.